P

Protagonist Therapeutics
D

PTGX

84.690
USD
1.38
(1.66%)
مغلق
حجم التداول
25,435
الربح لكل سهم
-2
العائد الربحي
-
P/E
128
حجم السوق
5,294,451,754
أصول ذات صلة الأخبار المقالات

العنوان: Protagonist Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Itspipeline products include Rusfertide (PTG-300) and JNJ-2113.